These accumulating mutations include TERT (telomerase reverse transcriptase) promoter mutations, components of the SWI/SNF (switch/sucrose non-fermentable or BAF) chromatin remodeling complex and loss of CDKN2A which are early events noted along the trajectory of nevus to melanoma transition [21]. This evidence concerns the gene CDKN2A and nevus.